Loading...
Loading...
RDY| Name | Value |
|---|---|
| Revenues | 68.8B |
| Cost of Revenue | 28.4B |
| Gross Profit | 40.4B |
| Operating Expense | 22.9B |
| Operating I/L | 17.9B |
| Other Income/Expense | 1.3B |
| Interest Income | 0.7B |
| Pretax | 19.1B |
| Income Tax Expense | 4.3B |
| Net Income/Loss | 14.8B |
Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company that operates globally. The company generates revenue through its Global Generics segment, which manufactures and markets prescription and over-the-counter pharmaceutical products, including biologics. Its Pharmaceutical Services and Active Ingredients (PSAI) segment produces active pharmaceutical ingredients and intermediates, and offers contract research services. Additionally, the company focuses on the research and development of differentiated formulations through its Proprietary Products segment. Dr. Reddy's Laboratories also engages in developing therapies in various therapeutic categories such as gastro-intestinal, cardiovascular, oncology, and respiratory.
